Communiqués Inhalation Sciences Sweden AB NORDIC GROWTH MARKET

Actions

ISAB

SE0009983893

Equipement et technologie médicale avancés

Cours en clôture NORDIC GROWTH MARKET Autres places de cotation 31/01/2024			Varia. 5j.	Varia. 1 janv.
4,340 ^SEK	+6,90%		-.--%	-

29/07	Inhalation Sciences sécurise un financement allant jusqu'à 4 millions de couronnes suédoises	FW
16/06	Inhalation Sciences reçoit une subvention de recherche de 0,4 million de couronnes	FW

Communiqués

18/05	Inhalation Sciences receives IRS order worth approximately EUR 117,000	AQ
24/03	Inhalation Sciences: Inhalation Sciences secures additional PreciseInhale® service orders worth SEK 350,000	PU
24/03	Inhalation Sciences secures additional PreciseInhale® service orders worth SEK 350,000	AQ
18/02	Inhalation Sciences receives new IRS order for DissolvIt® worth approximately EUR 139,000	AQ
27/01	Inhalation Sciences: Inhalation Sciences receives new IRS orders worth EUR 52,000 from global pharmaceutical companies	PU
27/01	Inhalation Sciences receives new IRS orders worth EUR 52,000 from global pharmaceutical companies	AQ
22/12	Inhalation Sciences receives major IRS order for DissolvIt® from leading global pharma company	AQ
11/12	Inhalation Sciences: Inhalation Sciences Presented FDA-Funded Study Results on DissolvIt® and the APRINHA Project at the DDL Conference	PU
11/12	Inhalation Sciences Presented FDA-Funded Study Results on DissolvIt® and the APRINHA Project at the DDL Conference	AQ
04/12	Inhalation Sciences receives purchase order worth 160 KEUR from international distributor for the US market	AQ
04/11	Inhalation Sciences: Inhalation Sciences hires advisors to evaluate potential acquirers of the company or the company's operations	PU
04/11	Inhalation Sciences hires advisors to evaluate potential acquirers of the company or the company's operations	AQ
24/10/25	Inhalation Sciences: Inhalation Sciences receives IRS order from leading European university hospital	PU
24/10/25	Inhalation Sciences receives IRS order from leading European university hospital	AQ
07/10/25	Inhalation Sciences: Inhalation Sciences to Present abstracts from the FDA-Funded Evaluation Study on DissolvIt® and the APRINHA Project at the 2025 DDL Conference	PU
07/10/25	Inhalation Sciences to Present abstracts from the FDA-Funded Evaluation Study on DissolvIt® and the APRINHA Project at the 2025 DDL Conference	AQ
02/10/25	Inhalation Sciences: Inhalation Sciences receives service orders from recurring global pharma customers	PU
02/10/25	Inhalation Sciences receives service orders from recurring global pharma customers	AQ
19/09/25	Inhalation Sciences: University of Liège highlights the value of PreciseInhale® in advancing Inhalation Research	PU
19/09/25	University of Liège highlights the value of PreciseInhale® in advancing Inhalation Research	AQ
17/09/25	Inhalation Sciences: Inhalation Sciences launches marketing campaign to increase awareness	PU
17/09/25	Inhalation Sciences launches marketing campaign to increase awareness	AQ
01/07/25	Inhalation Sciences: Inhalation Sciences receives service order from recurring global pharmaceutical customer	PU
01/07/25	Inhalation Sciences receives service order from recurring global pharmaceutical customer	AQ